Daclatasvir plus Sofosbuvir with or without Ribavirin for the Treatment of Chronic HCV Infection in Patients with Decompensated Cirrhosis: Results of a European Multicentre Compassionate Use Program
2016 ◽
Vol 64
(2)
◽
pp. S781-S782
◽
Keyword(s):